Category: Press Release

BI Faculty member and Chemical Engineering Professor Mike Solomon will serve as the next dean of Rackham Graduate School and vice provost for academic affairs-graduate studies.

A collaborative project from the Lahann, Luker and Krebsbach labs reports on new jet writing technique for printing 3D structures for biomedical applications.

We are pleased to announce our selection for the Diabetes and Its Complications Challenge seed fund competition.

Carlos Aguilar, Assistant Professor of Biomedical Engineering, and his research group recently joined BI. The Nano-Omic-Bio-Engineering Lab (NOBEL) is working on developing new approaches and tools to understand and investigate skeletal muscles.

Research in the Kotov group demonstrated the self-assembly of inorganic nanoparticles into nanoshells, which can potentially be used for gene delivery applications. More details here.

The Bioplasmonics Group, directed by Prof. Somin Lee, works at the interface between life science, physical science and engineering, drawing from a combination of bottom-up and top-down nanofabrication approaches, to design and develop smart biophotonic technologies and uncover biological complexities in the development of tissues and in cancer. Specifically, they have recently developed novel tools, including an mechano-optical plasmonic nanoantenna, to measure the temperature of proteins in cells. Prof. Lee received a Young Investigator Award from the Air Force Office of Scientific Research (AFOSR) to support this research.

Research in the Polymers Interfaces Surfaces (PSI) Group directed by Prof. Anish Tuteja focuses on developing polymers for energy and environmental applications. To date, the group has developed polymer systems for:

Drag reduction
Ice repelling
Drug delivery
Superhydrophobic and superoleophobic surfaces

Video

Sunitha Nagrath’s group is developing a device that incorporates nano-materials to allow for the isolation and analysis of circulating tumor cells from whole blood. In association with Dr. Scott McLean, the hope is that the research will predict the recurrence of melanoma after tumor removal.

In work started during his time at Rice University, Deepak Nagrath continues to research cancer cell metabolism and how cancer cells interact. Learning how the cells communicate could lead to new targets for more effective treatments than those currently is use.

Currently being used in a breast cancer clinical trial to isolate cancer cells in blood, Sunitha Nagrath and Max Wicha led the development of a hydrodynamic maze called the labyrinth chip. With its innovative design, the labyrinth chip allows researchers to capture cells for molecular analysis so they can know what to target with treatments.